Education
About Us
Working with TipRanks
Follow Us
Renovaro Biosciences (RENB)
NASDAQ:RENB
Renovaro Biosciences (RENB) Ownership Overview
41.95% Insiders
4.36% Mutual Funds
0.21% Other Institutional Investors
5.84% ETFs
47.63% Public Companies and
Individual Investors
The ownership structure of Renovaro Biosciences (RENB) stock is a mix of institutional, retail, and individual investors. Approximately 10.42% of the company’s stock is owned by Institutional Investors, 41.95% is owned by Insiders, and 47.63% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 24, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $1448 |
| Jul 19, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $23889 |
| Jul 17, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $30955 |
| Jul 15, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $142827 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 23,372,969 | Insider | 14.39% | 18,815,240 | |
| 18,133,196 | Insider | 11.17% | 14,597,223 | |
| 13,605,297 | Insider | 8.38% | 10,952,264 | |
| 11,162,447 | Insider | 7.60% | 8,985,770 | |
| 5,367,400 | Institution | 3.31% | 4,320,757 | |
| 4,746,608 | Institution | 2.92% | 3,821,019 | |
| 3,895,560 | Institution | 2.40% | 3,135,926 | |
| 813,716 | Institution | 0.50% | 655,041 | |
| 594,211 | Institution | 0.37% | 478,340 | |
| 275,750 | Institution | 0.17% | 221,979 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,746,608 | Institution | 2.92% | 3,821,019 | |
| 813,716 | Institution | 0.50% | 655,041 | |
| 594,211 | Institution | 0.37% | 478,340 | |
| 275,750 | Institution | 0.17% | 221,979 | |
| 198,966 | Institution | 0.12% | 160,168 | |
| 70,239 | Institution | 0.04% | 56,542 | |
| 66,288 | Institution | 0.04% | 53,362 | |
| 64,442 | Institution | 0.04% | 51,876 | |
| 49,656 | Institution | 0.03% | 39,973 | |
| 45,797 | Institution | 0.03% | 36,867 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,341,900 | Institution | 2.06% | 3,283,751 | |
| 2,658,585 | Institution | 1.64% | 2,140,693 | |
| 1,404,708 | Institution | 0.87% | 1,380,266 | |
| 618,498 | Institution | 0.38% | 498,015 | |
| 524,453 | Institution | 0.32% | 515,328 | |
| 355,876 | Institution | 0.22% | 286,551 | |
| 262,601 | Institution | 0.16% | 211,446 | |
| 67,337 | Institution | 0.04% | 66,165 | |
| 66,601 | Institution | 0.04% | 52,695 | |
| 29,357 | Institution | 0.02% | 22,018 |
FAQ
Who Owns Renovaro Biosciences (RENB)?
According to the latest TipRanks data, approximately 0.21% of the company's stock is held by institutional investors, 41.95% is held by insiders, and 47.63% is held by retail investors.
What percentage of Renovaro Biosciences (RENB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.21% of Renovaro Biosciences (RENB) stock is held by institutional investors.
What percentage of Renovaro Biosciences (RENB) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.63% of Renovaro Biosciences (RENB) stock is held by retail investors.
Who owns the most shares of Renovaro Biosciences (RENB)?
Karen Brink owns the most shares of Renovaro Biosciences (RENB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.